Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Immunity. 2022 Sep 13;55(9):1749. doi: 10.1016/j.immuni.2022.07.021.
No abstract available

Publication types

  • Published Erratum